Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
OGI.TOthis companyOrganigram Global Inc.	CA$1.26	-14.84×	1.03×	1.39×	-13.88×	-3094.3%	3.7%	-34.1%	-9.6%	-7.1%	-13.0%	-6.8%	0.03×	3.64×	0×	2.26×	0.0%	5	-0.07	4	A
ACB.TOAurora Cannabis Inc.	CA$7.44	-2.13×	0.51×	0.81×	-1.15×	-669.8%	5.2%	-50.8%	-38.0%	-23.8%	-30.2%	-13.9%	0.05×	0.6×	-89.99×	5.94×	0.0%	1	-12.15	2	C+
CPH.TOCipher Pharmaceuticals Inc.	CA$13.57	10.06×	2.22×	5.44×	11.52×	423.7%	65.8%	32.7%	54.2%	22.1%	12.8%	10.8%	0.04×	-0.08×	14.17×	1.12×	0.0%	6	9.06	5	S-
DR.TOMedical Facilities Corporation	CA$15.34	10.6×	2.99×	0.87×	3.81×	67.8%	38.0%	18.4%	8.2%	28.0%	19.5%	18.2%	0.78×	0.24×	13.23×	1.79×	2.3%	8	2.15	4	A
EPRX.TOEupraxia Pharmaceuticals Inc.	CA$10.34	-9.83×	5.04×	0×	-8.54×	-78.4%	0.0%	0.0%	0.0%	-47.9%	-48.6%	-7.2%	0×	2.07×	0×	15.12×	0.0%	2	34.16	2	C
HLS.TOHLS Therapeutics Inc.	CA$4.38	-8.77×	1.8×	1.96×	8.25×	26.6%	42.5%	-7.4%	-22.4%	-20.5%	-3.5%	14.3%	0.81×	2.11×	-0.58×	1.11×	0.0%	5	-1.12	2	C+
Peer median	—	-2.13×	2.22×	0.87×	3.81×	26.6%	38.0%	0.0%	0.0%	-20.5%	-3.5%	10.8%	0.05×	0.6×	0×	1.79×	0.0%	5	2.15	2	—